Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early IV to Oral Antibiotic Switch in Uncomplicated Staph Aureus Bacteraemia (EVOS)
NCT06336824Phase 3Recruiting
- Sponsor
- Clinical Research Malaysia
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in Staphylococcus aureus bacteremia (SAB), sponsored by Clinical Research Malaysia. Started Jun 2024; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT06336824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336824.